2019 Q4 Form 10-Q Financial Statement

#000105635819000103 Filed on November 08, 2019

View on sec.gov

Income Statement

Concept 2019 Q4 2019 Q3 2019 Q1
Revenue $39.40M $39.70M $38.00M
YoY Change -10.45% -7.7% -8.21%
Cost Of Revenue $8.300M $7.711M $7.427M
YoY Change -8.79% -14.67% -9.96%
Gross Profit $31.10M $31.95M $30.55M
YoY Change -11.14% -5.98% -7.81%
Gross Profit Margin 78.93% 80.47% 80.38%
Selling, General & Admin $22.50M $26.20M $23.50M
YoY Change -18.48% 0.0% -6.0%
% of Gross Profit 72.35% 82.02% 76.93%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $530.0K $519.0K $528.0K
YoY Change -1.85% 9.26% 3.33%
% of Gross Profit 1.7% 1.62% 1.73%
Operating Expenses $28.40M $31.38M $29.43M
YoY Change -19.77% -2.87% -13.51%
Operating Profit $2.700M $565.0K $1.120M
YoY Change -775.0% -66.17% -226.13%
Interest Expense $100.0K $0.00 -$100.0K
YoY Change 0.0% -100.0%
% of Operating Profit 3.7% 0.0% -8.93%
Other Income/Expense, Net -$1.200M -$430.0K $4.000K
YoY Change 200.0% 418.07% -98.61%
Pretax Income $1.600M $123.0K $1.029M
YoY Change -300.0% -92.49% -280.21%
Income Tax -$500.0K $1.613M $341.0K
% Of Pretax Income -31.25% 1311.38% 33.14%
Net Earnings $2.100M -$1.490M $688.0K
YoY Change -231.25% -10.4% -360.61%
Net Earnings / Revenue 5.33% -3.75% 1.81%
Basic Earnings Per Share -$0.62 $0.29
Diluted Earnings Per Share $875.0K -$0.62 $0.28
COMMON SHARES
Basic Shares Outstanding 2.386M shares 2.391M shares 2.396M shares
Diluted Shares Outstanding 2.391M shares 2.462M shares

Balance Sheet

Concept 2019 Q4 2019 Q3 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $24.80M $25.80M $19.60M
YoY Change 13.76% 0.39% -48.28%
Cash & Equivalents $24.76M $25.75M $19.59M
Short-Term Investments
Other Short-Term Assets $9.600M $5.700M $7.700M
YoY Change 29.73% -30.49% -16.3%
Inventory $10.20M $12.20M $13.34M
Prepaid Expenses
Receivables $955.0K $176.0K $143.0K
Other Receivables $200.0K $100.0K $300.0K
Total Short-Term Assets $41.03M $43.96M $40.56M
YoY Change -3.2% -5.92% -28.4%
LONG-TERM ASSETS
Property, Plant & Equipment $6.100M $12.80M $11.40M
YoY Change -9.82% 85.51% 107.27%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $9.600M $10.43M $8.595M
YoY Change 146.15% 172.54% 117.93%
Total Long-Term Assets $21.89M $22.85M $24.88M
YoY Change 10.51% 1.92% 11.24%
TOTAL ASSETS
Total Short-Term Assets $41.03M $43.96M $40.56M
Total Long-Term Assets $21.89M $22.85M $24.88M
Total Assets $62.92M $66.81M $65.44M
YoY Change 1.17% -3.38% -17.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.526M $4.675M $5.880M
YoY Change -47.56% -26.98% 7.83%
Accrued Expenses $8.209M $10.19M $7.440M
YoY Change 36.93% 54.04% 29.98%
Deferred Revenue $4.400M $5.702M $5.393M
YoY Change -16.57% -18.07% -37.33%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $800.0K $800.0K $1.100M
YoY Change 0.0% -11.11% 0.0%
Total Short-Term Liabilities $28.89M $34.82M $33.39M
YoY Change -14.05% -4.0% -3.58%
LONG-TERM LIABILITIES
Long-Term Debt $500.0K $700.0K $800.0K
YoY Change -50.0% -36.36% 700.0%
Other Long-Term Liabilities $6.200M $6.644M $5.575M
YoY Change 169.57% 137.63% 95.61%
Total Long-Term Liabilities $6.200M $6.644M $5.575M
YoY Change 169.57% 137.63% 95.61%
TOTAL LIABILITIES
Total Short-Term Liabilities $28.89M $34.82M $33.39M
Total Long-Term Liabilities $6.200M $6.644M $5.575M
Total Liabilities $35.65M $42.16M $39.79M
YoY Change -3.32% 2.16% 2.68%
SHAREHOLDERS EQUITY
Retained Earnings -$690.0K -$2.499M -$2.397M
YoY Change -75.2% 83200.0% -166.84%
Common Stock $0.00 $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $9.935M $9.861M $9.758M
YoY Change -2.31% -3.43% 240.24%
Treasury Stock Shares 361.7K shares 357.1K shares 347.6K shares
Shareholders Equity $27.28M $24.65M $25.65M
YoY Change
Total Liabilities & Shareholders Equity $62.92M $66.81M $65.44M
YoY Change 1.17% -3.38% -17.17%

Cashflow Statement

Concept 2019 Q4 2019 Q3 2019 Q1
OPERATING ACTIVITIES
Net Income $2.100M -$1.490M $688.0K
YoY Change -231.25% -10.4% -360.61%
Depreciation, Depletion And Amortization $530.0K $519.0K $528.0K
YoY Change -1.85% 9.26% 3.33%
Cash From Operating Activities -$1.230M $2.340M -$89.00K
YoY Change -35.26% -11800.0% -109.13%
INVESTING ACTIVITIES
Capital Expenditures -$220.0K -$320.0K $429.0K
YoY Change -50.0% -61.45% 52.13%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities -$220.0K -$320.0K -$429.0K
YoY Change -51.11% -60.98% 52.67%
FINANCING ACTIVITIES
Cash Dividend Paid $303.0K
YoY Change -10.88%
Common Stock Issuance & Retirement, Net $9.000K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -620.0K -750.0K -$559.0K
YoY Change -61.96% -65.44% -20.6%
NET CHANGE
Cash From Operating Activities -1.230M 2.340M -$89.00K
Cash From Investing Activities -220.0K -320.0K -$429.0K
Cash From Financing Activities -620.0K -750.0K -$559.0K
Net Change In Cash -2.070M 1.270M -$1.503M
YoY Change -47.99% -142.19% -621.88%
FREE CASH FLOW
Cash From Operating Activities -$1.230M $2.340M -$89.00K
Capital Expenditures -$220.0K -$320.0K $429.0K
Free Cash Flow -$1.010M $2.660M -$518.0K
YoY Change -30.82% 228.4% -174.75%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Document Period End Date
DocumentPeriodEndDate
2019-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001056358
CY2019Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2385787 shares
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
MANNATECH INC
dei Entity Shell Company
EntityShellCompany
false
dei Entity Small Business
EntitySmallBusiness
true
CY2018Q4 mtex Accrued Lease Restoration Costs
AccruedLeaseRestorationCosts
400000 USD
CY2019Q3 mtex Accrued Lease Restoration Costs
AccruedLeaseRestorationCosts
400000 USD
CY2018Q3 mtex Average Share Price
AverageSharePrice
19.91
mtex Average Share Price
AverageSharePrice
18.06
CY2019Q3 mtex Average Share Price
AverageSharePrice
16.16
mtex Average Share Price
AverageSharePrice
17.50
CY2018Q3 mtex Commissions And Incentives Expense
CommissionsAndIncentivesExpense
18054000 USD
mtex Commissions And Incentives Expense
CommissionsAndIncentivesExpense
54361000 USD
CY2019Q3 mtex Commissions And Incentives Expense
CommissionsAndIncentivesExpense
16696000 USD
mtex Commissions And Incentives Expense
CommissionsAndIncentivesExpense
48190000 USD
CY2018Q4 mtex Commissions And Incentives Payable
CommissionsAndIncentivesPayable
12189000 USD
CY2019Q3 mtex Commissions And Incentives Payable
CommissionsAndIncentivesPayable
10335000 USD
CY2018 mtex Customer Contract Loyalty Points Forfeited
CustomerContractLoyaltyPointsForfeited
4332000 USD
mtex Customer Contract Loyalty Points Forfeited
CustomerContractLoyaltyPointsForfeited
3487000 USD
CY2018 mtex Customer Contract Loyalty Points Vested
CustomerContractLoyaltyPointsVested
12469000 USD
mtex Customer Contract Loyalty Points Vested
CustomerContractLoyaltyPointsVested
8441000 USD
CY2018 mtex Customer Contracts Loyalty Points Used
CustomerContractsLoyaltyPointsUsed
11398000 USD
mtex Customer Contracts Loyalty Points Used
CustomerContractsLoyaltyPointsUsed
6720000 USD
CY2018 mtex Customer Loyalty Points Unvested
CustomerLoyaltyPointsUnvested
1086000 USD
mtex Customer Loyalty Points Unvested
CustomerLoyaltyPointsUnvested
1114000 USD
CY2017Q4 mtex Customer Loyalty Program Contract Liability Current
CustomerLoyaltyProgramContractLiabilityCurrent
6406000 USD
CY2018Q4 mtex Customer Loyalty Program Contract Liability Current
CustomerLoyaltyProgramContractLiabilityCurrent
4200000 USD
CY2018Q4 mtex Customer Loyalty Program Contract Liability Current
CustomerLoyaltyProgramContractLiabilityCurrent
4231000 USD
CY2019Q3 mtex Customer Loyalty Program Contract Liability Current
CustomerLoyaltyProgramContractLiabilityCurrent
3579000 USD
CY2019Q3 mtex Customer Loyalty Program Contract Liability Current
CustomerLoyaltyProgramContractLiabilityCurrent
3600000 USD
CY2019Q3 mtex Financeand Operating Lease Assets
FinanceandOperatingLeaseAssets
6793000 USD
CY2019Q3 mtex Financeand Operating Lease Liabilities
FinanceandOperatingLeaseLiabilities
7988000 USD
mtex Interest Paid On Capital Leases And Financing Arrangements
InterestPaidOnCapitalLeasesAndFinancingArrangements
93000 USD
mtex Non Cash Finance Lease Right Of Use Assets And Lease Liabilities
NonCashFinanceLeaseRightOfUseAssetsAndLeaseLiabilities
0 USD
mtex Non Cash Finance Lease Right Of Use Assets And Lease Liabilities
NonCashFinanceLeaseRightOfUseAssetsAndLeaseLiabilities
76000 USD
mtex Non Cash Operating Lease Right Of Use Assets And Lease Liabilities
NonCashOperatingLeaseRightOfUseAssetsAndLeaseLiabilities
0 USD
mtex Non Cash Operating Lease Right Of Use Assets And Lease Liabilities
NonCashOperatingLeaseRightOfUseAssetsAndLeaseLiabilities
4730000 USD
mtex Increase Decrease In Capitalized Contract Costs
IncreaseDecreaseInCapitalizedContractCosts
-756000 USD
mtex Increase Decrease In Capitalized Contract Costs
IncreaseDecreaseInCapitalizedContractCosts
-93000 USD
mtex Increase Decrease In Commissions And Incentives Payable
IncreaseDecreaseInCommissionsAndIncentivesPayable
1832000 USD
mtex Interest Paid On Capital Leases And Financing Arrangements
InterestPaidOnCapitalLeasesAndFinancingArrangements
38000 USD
mtex Increase Decrease In Commissions And Incentives Payable
IncreaseDecreaseInCommissionsAndIncentivesPayable
-1854000 USD
mtex Number Of Countries In Which Entity Network Marketing And Distribution Channels Operates
NumberOfCountriesInWhichEntityNetworkMarketingAndDistributionChannelsOperates
25 country
mtex Number Of Countries In Which Entity Sells Products
NumberOfCountriesInWhichEntitySellsProducts
26 country
mtex Number Of Regions In Which Company Sells Products
NumberOfRegionsInWhichCompanySellsProducts
3 region
mtex Operating Right Of Use Lease Liabilities Net
OperatingRightOfUseLeaseLiabilitiesNet
0 USD
mtex Operating Right Of Use Lease Liabilities Net
OperatingRightOfUseLeaseLiabilitiesNet
1219000 USD
mtex Percentage Of Sale Returns
PercentageOfSaleReturns
0.015
CY2018Q4 mtex Property Plant And Equipment Net Excluding Construction In Progress
PropertyPlantAndEquipmentNetExcludingConstructionInProgress
5860000 USD
CY2019Q3 mtex Property Plant And Equipment Net Excluding Construction In Progress
PropertyPlantAndEquipmentNetExcludingConstructionInProgress
5563000 USD
CY2018Q3 mtex Sales Revenue Goods Percentage
SalesRevenueGoodsPercentage
1.000
mtex Sales Revenue Goods Percentage
SalesRevenueGoodsPercentage
1.000
CY2019Q3 mtex Sales Revenue Goods Percentage
SalesRevenueGoodsPercentage
1.000
mtex Sales Revenue Goods Percentage
SalesRevenueGoodsPercentage
1.000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6724000 USD
CY2019Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
4675000 USD
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
106000 USD
CY2019Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
176000 USD
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5995000 USD
CY2019Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10193000 USD
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
4337000 USD
CY2019Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2944000 USD
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
33939000 USD
CY2019Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
34061000 USD
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
36000 USD
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
590000 USD
CY2018Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
139000 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
107000 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
160000 USD
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
106000 USD
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
800000 USD
CY2019Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
600000 USD
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
770000 USD
CY2019Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
623000 USD
CY2018Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
400000 shares
CY2019Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
300000 shares
CY2018Q4 us-gaap Assets
Assets
62198000 USD
CY2019Q3 us-gaap Assets
Assets
66806000 USD
CY2018Q4 us-gaap Assets Current
AssetsCurrent
42387000 USD
CY2019Q3 us-gaap Assets Current
AssetsCurrent
43955000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
25000 USD
CY2018Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
75000 USD
CY2019Q3 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
99000 USD
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
2281000 USD
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
0 USD
CY2018Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
72000 USD
CY2019Q3 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
201000 USD
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
1200000 USD
CY2018Q4 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
2449000 USD
CY2019Q3 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
2356000 USD
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
37682000 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21845000 USD
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
25753000 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
46761000 USD
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
34460000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30584000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
32301000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-12301000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1717000 USD
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.125
CY2019Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.125
CY2019Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.125
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
99000000 shares
CY2019Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
99000000 shares
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2742857 shares
CY2019Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2742857 shares
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2381149 shares
CY2019Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2385787 shares
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
0 USD
CY2019Q3 us-gaap Common Stock Value
CommonStockValue
0 USD
CY2018Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1728000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4067000 USD
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2253000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-209000 USD
CY2018Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
904000 USD
CY2019Q3 us-gaap Construction In Progress Gross
ConstructionInProgressGross
830000 USD
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
5274000 USD
CY2019Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
5702000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
3200000 USD
CY2018Q3 us-gaap Cost Of Revenue
CostOfRevenue
9037000 USD
us-gaap Cost Of Revenue
CostOfRevenue
25426000 USD
CY2019Q3 us-gaap Cost Of Revenue
CostOfRevenue
7711000 USD
us-gaap Cost Of Revenue
CostOfRevenue
23253000 USD
CY2018Q4 us-gaap Credit Card Receivables
CreditCardReceivables
1600000 USD
CY2019Q3 us-gaap Credit Card Receivables
CreditCardReceivables
1700000 USD
CY2018Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1928000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-261000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
999000 USD
CY2019Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
929000 USD
CY2018Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
3000 USD
CY2019Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
3000 USD
CY2018Q4 us-gaap Deposit Assets
DepositAssets
1700000 USD
CY2019Q3 us-gaap Deposit Assets
DepositAssets
1500000 USD
CY2018Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
475000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1521000 USD
CY2019Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
519000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1564000 USD
CY2019Q1 us-gaap Dividends
Dividends
300000 USD
CY2019Q2 us-gaap Dividends
Dividends
300000 USD
CY2019Q3 us-gaap Dividends
Dividends
300000 USD
CY2018Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
340000 USD
CY2018Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
340000 USD
CY2018Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1202000 USD
CY2019Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
303000 USD
CY2019Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
300000 USD
CY2019Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
299000 USD
CY2018Q4 us-gaap Due From Banks
DueFromBanks
19900000 USD
CY2019Q3 us-gaap Due From Banks
DueFromBanks
22900000 USD
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.69
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.89
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.62
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.50
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.69
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.89
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.62
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.47
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1720000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1346000 USD
CY2018Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
1.678
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
2.985
CY2019Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
13.114
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.716
CY2019Q3 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
25000 USD
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
186000 USD
CY2019Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
300000 USD
CY2019Q3 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
335000 USD
CY2019Q3 us-gaap Finance Lease Liability Payments Due After Year Five
FinanceLeaseLiabilityPaymentsDueAfterYearFive
10000 USD
CY2019Q3 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
36000 USD
CY2019Q3 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
63000 USD
CY2019Q3 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
89000 USD
CY2019Q3 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
99000 USD
CY2019Q3 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
38000 USD
CY2019Q3 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
35000 USD
CY2019Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.058
CY2019Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P3Y6M15D
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
2012000 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-62000 USD
CY2018Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8111000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
25706000 USD
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8951000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
24908000 USD
CY2018Q3 us-gaap Gross Profit
GrossProfit
33977000 USD
us-gaap Gross Profit
GrossProfit
104108000 USD
CY2019Q3 us-gaap Gross Profit
GrossProfit
31945000 USD
us-gaap Gross Profit
GrossProfit
95087000 USD
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1637000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1327000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
123000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
4175000 USD
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3300000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3637000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1613000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2991000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
381000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1089000 USD
CY2018Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
291000 USD
CY2019Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
119000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
394000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2049000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
261000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
38000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
1521000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
444000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1020000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-177000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1601000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
428000 USD
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-907000 USD
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-172000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3821000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
199000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-50000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-850000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-17000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1976000 USD
CY2018Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
200000 USD
CY2019Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
200000 USD
CY2018Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
50000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
212000 USD
CY2019Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-12000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-83000 USD
CY2018Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
12542000 USD
CY2019Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
10620000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
410000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-32000 USD
CY2018Q4 us-gaap Inventory Net
InventoryNet
12821000 USD
CY2018Q4 us-gaap Inventory Net
InventoryNet
12800000 USD
CY2019Q3 us-gaap Inventory Net
InventoryNet
12162000 USD
CY2019Q3 us-gaap Inventory Net
InventoryNet
12200000 USD
CY2018Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
803000 USD
CY2019Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
2402000 USD
CY2018Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
524000 USD
CY2019Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
860000 USD
us-gaap Inventory Write Down
InventoryWriteDown
495000 USD
us-gaap Inventory Write Down
InventoryWriteDown
857000 USD
us-gaap Lease Cost
LeaseCost
1668000 USD
CY2019Q3 us-gaap Lease Cost
LeaseCost
592000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
8825000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
2752000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
605000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1177000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1648000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2002000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
641000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1137000 USD
CY2018Q4 us-gaap Liabilities
Liabilities
36874000 USD
CY2019Q3 us-gaap Liabilities
Liabilities
42161000 USD
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
62198000 USD
CY2019Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
66806000 USD
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
33614000 USD
CY2019Q3 us-gaap Liabilities Current
LiabilitiesCurrent
34818000 USD
CY2018Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
200000 USD
CY2019Q3 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
200000 USD
CY2018Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
883000 USD
CY2019Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
495000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-10426000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2091000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1833000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-998000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1678000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
6152000 USD
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-264000 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-384000 USD
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-1663000 USD
us-gaap Net Income Loss
NetIncomeLoss
-2310000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
688000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
1987000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-1490000 USD
us-gaap Net Income Loss
NetIncomeLoss
1184000 USD
CY2018Q4 us-gaap Noncurrent Assets
NoncurrentAssets
6800000 USD
CY2019Q3 us-gaap Noncurrent Assets
NoncurrentAssets
6100000 USD
CY2018Q4 us-gaap Notes Payable
NotesPayable
1600000 USD
CY2019Q3 us-gaap Notes Payable
NotesPayable
1200000 USD
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1670000 USD
CY2018Q4 us-gaap Notes Payable Current
NotesPayableCurrent
702000 USD
CY2019Q3 us-gaap Notes Payable Current
NotesPayableCurrent
715000 USD
CY2019Q3 us-gaap Number Of Countries In Which Entity Operates
NumberOfCountriesInWhichEntityOperates
12 country
us-gaap Operating Income Loss
OperatingIncomeLoss
3704000 USD
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
32307000 USD
us-gaap Operating Expenses
OperatingExpenses
103674000 USD
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
31380000 USD
us-gaap Operating Expenses
OperatingExpenses
91383000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
434000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
565000 USD
CY2019Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.041
CY2019Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
7688000 USD
CY2019Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
592000 USD
CY2019Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y0M0D
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3894000 USD
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3900000 USD
CY2019Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10433000 USD
CY2018Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
334000 USD
CY2018Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2026000 USD
CY2018Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-65000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1757000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-441000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-189000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-763000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1393000 USD
CY2018Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
5667000 USD
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
22086000 USD
CY2019Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
5214000 USD
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
16721000 USD
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2302000 USD
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2300000 USD
CY2019Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6644000 USD
CY2018Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-83000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
681000 USD
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-430000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
554000 USD
us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
-62000 USD
us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
0 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
7443000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
221000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
1883000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
902000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1895000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
998000 USD
CY2018Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Current And Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent
400000 USD
CY2019Q2 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Current And Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent
300000 USD
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2019Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3361000 USD
CY2019Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1937000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
15000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
1115000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
968000 USD
CY2018Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
8700000 USD
CY2019Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
6500000 USD
CY2018Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1514000 USD
CY2019Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1452000 USD
CY2018Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
7225000 USD
CY2019Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
5096000 USD
CY2017Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
1514000 USD
CY2018Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
1514000 USD
CY2019Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
1452000 USD
CY2017Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
7565000 USD
CY2018Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
7225000 USD
CY2019Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
5096000 USD
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2782000 USD
CY2019Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2499000 USD
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
43014000 USD
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
43000000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
129500000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
129534000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
39656000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
39700000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
118340000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
118300000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
0 USD
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
236000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2916000 USD
CY2018Q2 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
16000000 USD
CY2018Q2 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
6600000 USD
CY2018Q2 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
316659 shares
CY2018Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
21.00
CY2018Q4 us-gaap Security Deposit
SecurityDeposit
2000000 USD
CY2019Q3 us-gaap Security Deposit
SecurityDeposit
2200000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1009000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
653000 USD
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
370000 shares
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
156767 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
184667 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
15000 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
7.29
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
6.88
CY2018Q1 us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
245000 USD
CY2018Q3 us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
-1000 USD
CY2019Q1 us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
280000 USD
CY2019Q3 us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
0 USD
CY2018Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
15000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-1000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
40241000 USD
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
40252000 USD
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
31262000 USD
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
27872000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
25324000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
25646000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
27245000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
24645000 USD
CY2018Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
2655000 USD
CY2019Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
3099000 USD
CY2018Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
361708 shares
CY2019Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
357070 shares
CY2018Q3 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
24868 shares
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
341527 shares
CY2019Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
9560 shares
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
14097 shares
CY2018Q4 us-gaap Treasury Stock Value
TreasuryStockValue
10170000 USD
CY2019Q3 us-gaap Treasury Stock Value
TreasuryStockValue
9861000 USD
CY2018Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
6830000 USD
CY2018Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
613000 USD
CY2019Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
9000 USD
CY2019Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
58000 USD
CY2019Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
154000 USD
CY2018Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2396000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2595000 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2391000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2450000 shares
CY2018Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2396000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2595000 shares
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2391000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2393000 shares
us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">LITIGATION</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:underline;">Administrative Proceeding</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Mannatech Korea, Ltd. v. Busan Custom Office</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">, Busan District Court, Korea</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On or before April 12, 2015, Mannatech Korea, Ltd. filed a suit against the Busan Custom Office (&#8220;BCO&#8221;) to challenge BCO&#8217;s method of calculation regarding its assessment notice issued on July 11, 2013. The assessment notice included an audit of the Company&#8217;s imported goods covering fiscal years 2008 through 2012 and required the Company to pay </font><font style="font-family:inherit;font-size:10pt;">$1.0 million</font><font style="font-family:inherit;font-size:10pt;"> for this assessment, all of which was paid in January 2014.&#160;Both parties submitted a response to the Court&#8217;s inquiry on January 15, 2016. The final hearing for the case was held on May 26, 2016 where each party presented their respective arguments. The Court set the decision hearing on October 27, 2016, and the Court decided the case in the Company&#8217;s favor. However, on November 18, 2016, BCO filed an appeal to the Busan High Court. The first hearing occurred on March 31, 2017, and the second hearing occurred on April 21, 2017. The final hearing was held on June 2, 2017. The Court issued its decision on June 30, 2017 in favor of the BCO. The Company appealed this decision on August 24, 2017. Since the appeal of the decision of the Busan High Court to the Supreme Court, there have been no further developments and the Company is still awaiting the decision of the Supreme Court. This matter remains open.</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:174%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"></font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:underline;">Litigation - Product Liability</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Ruiguo Ma v. MTEX Hong Kong Limited and Beili Guan, Case No. 2019-Jin-0116-Civil-2339, Binhai New District Court, Tianjin, China</font></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On March 29, 2019, the Company was informed by one of its independent distributors, Beili Guan, of a potential lawsuit in China. The Company has not been served but confirmed the above-captioned lawsuit with the court. Ruiguo Ma (the &#8220;Plaintiff&#8221;) is alleging that his child suffered tooth decay after consuming Mannatech&#8217;s MannaBears product and underwent several surgeries. The Plaintiff is seeking damages of approximately $50,000 USD. The Company has engaged local counsel to defend this case. The Company has provided notice to its insurance carrier. At this time the potential damages do not meet the deductible; therefore, the case has not been tendered to the carrier.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">It is not possible at this time to predict whether the Company will incur any liability, or to estimate the ranges of damages, if any, which may be incurred in connection with this matter. However, the Company believes it has a valid defense and will vigorously defend this claim. This matter remains open.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Hong Wang v. Meitai Daily Necessities &amp; Health Products Co. Ltd. and Beili Guan</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">, Case No. 2019-Ao-0491-Civil-986, Hengqin New District, Zhuhai, China </font></div><div style="line-height:120%;text-align:justify;padding-left:120px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On May 16, 2019, the Company&#8217;s Guangzhou office received service of process of the above-captioned matter. Hong Wang (the &#8220;Plaintiff&#8221;) is a customer in China. Plaintiff alleges that Company products, Manapol and Truplenish sold through Meitaichina.com, are in violation of the China Food Safety Law and deceive consumers. Plaintiff provides in the evidence that China Food Safety Law requires food or supplements containing &#8220;aloe vera gel&#8221; to have warnings stating that the product is not recommended for pregnant women or children under the age of three. Plaintiff is seeking damages of approximately $8,000. The Company has engaged local counsel to defend this case. The Company has provided notice to its insurance carrier. At this time the potential damages do not meet the deductible; therefore, the case has not been tendered to the carrier. The parties attended the hearing and presented their arguments on July 25, 2019. The Company has subsequently added warning labels for its products that contain aloe vera. On August 14, 2019, the parties entered into a settlement agreement in an amount equal to $5,381.25 USD. The Company considers this matter closed.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:underline;">Litigation in</font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"> </font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:underline;">General</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has incurred several claims in the normal course of business. The Company believes such claims can be resolved without any material adverse effect on our consolidated financial position, results of operations, or cash flows.</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company maintains certain liability insurance; however, certain costs of defending lawsuits are not covered by or only partially covered by its insurance policies, including claims that are below insurance deductibles. Additionally, insurance carriers could refuse to cover certain claims, in whole or in part. The Company accrues costs to defend itself from litigation as they are incurred.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The outcome of litigation is uncertain, and despite management&#8217;s views of the merits of any litigation, or the reasonableness of the Company&#8217;s estimates and reserves, the Company&#8217;s financial statements could nonetheless be materially affected by an adverse judgment. The Company believes it has adequately reserved for the contingencies arising from current legal matters where an outcome was deemed to be probable, and the loss amount could be reasonably estimated.</font></div></div>
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of the Company&#8217;s consolidated financial statements in accordance with GAAP requires the use of estimates that affect the reported value of assets, liabilities, revenues and expenses. These estimates are based on historical experience and various other factors. The Company continually evaluates the information used to make these estimates as the business and economic environment changes. Historically, actual results have not varied materially from the Company&#8217;s estimates and the Company does not currently anticipate a significant change in its assumptions related to these estimates. However, actual results may differ from these estimates under different assumptions or conditions.</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The use of estimates is pervasive throughout the consolidated financial statements, but the accounting policies and estimates considered the most significant are described in this note to the consolidated financial statements, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Organization and Summary of Significant Accounting Policies</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>

Files In Submission

Name View Source Status
0001056358-19-000103-index-headers.html Edgar Link pending
0001056358-19-000103-index.html Edgar Link pending
0001056358-19-000103.txt Edgar Link pending
0001056358-19-000103-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
mtex-20190930.xml Edgar Link completed
mtex-20190930.xsd Edgar Link pending
mtex-20190930_cal.xml Edgar Link unprocessable
mtex-20190930_def.xml Edgar Link unprocessable
mtex-20190930_lab.xml Edgar Link unprocessable
mtex-20190930_pre.xml Edgar Link unprocessable
mtex0930201910-q.htm Edgar Link pending
mtexq3201910-qexh311.htm Edgar Link pending
mtexq3201910-qexh312.htm Edgar Link pending
mtexq3201910-qexh321.htm Edgar Link pending
mtexq3201910-qexh322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending